End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,03,600 KRW | +0.48% | -0.67% | -20.86% |
Business Summary
Number of employees: 2,291
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 1,488,345 | 100.0 % | 1,669,404 | 100.0 % | +12.17% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
89.4
%
| 1,423,245 | 95.6 % | 1,493,073 | 89.4 % | +4.91% |
Switzerland
6.4
%
| - | - | 106,064 | 6.4 % | - |
Japan
2.5
%
| 45,891 | 3.1 % | 41,157 | 2.5 % | -10.32% |
Others
1.7
%
| 8,626 | 0.6 % | 29,110 | 1.7 % | +237.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Young-Ju Kim
CEO | Chief Executive Officer | 60 | 20/15/20 |
Jong-Rae Lim
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Ja-Min Gu
BRD | Director/Board Member | 60 | - |
Chang-Gyu Kim
BRD | Director/Board Member | 68 | - |
Jong-Han Park
PRN | Corporate Officer/Principal | 61 | - |
Ho-Seong Yoo
PRN | Corporate Officer/Principal | 64 | - |
Yeo-Wook Go
PRN | Corporate Officer/Principal | 61 | - |
Hong-Soon Park
PRN | Corporate Officer/Principal | 68 | - |
Jong-Han Kang
SAM | Sales & Marketing | 57 | - |
Dae-Gil Bae
PRN | Corporate Officer/Principal | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chang-Gyu Kim
BRD | Director/Board Member | 68 | - |
Seong-Gon Kim
BRD | Director/Board Member | 62 | - |
Ja-Min Gu
BRD | Director/Board Member | 60 | - |
Young-Ju Kim
CEO | Chief Executive Officer | 60 | 20/15/20 |
Ki-Won Kim
BRD | Director/Board Member | 59 | - |
Soon-Wook Hong
BRD | Director/Board Member | 68 | 15/19/15 |
In-Soo Kang
BRD | Director/Board Member | 63 | 15/19/15 |
Dong-Shin Chang
BRD | Director/Board Member | 55 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,174,420 | 6,908,366 ( 52.44 %) | 471,810 ( 3.581 %) | 52.44 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
381,024 | 2.89% | 31,189,485 $ |
Company contact information
Chong Kun Dang Pharmaceutical Corp.
8 Chungjeong-ro Seondaemun-gu
03742, Seoul
+
http://www.ckdpharm.comSector
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.86% | 967M | |
+18.67% | 43.74B | |
+21.99% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-9.64% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.41% | 5.47B |
- Stock Market
- Equities
- A185750 Stock
- Company Chong Kun Dang Pharmaceutical Corp.